| 000 | 01709 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516201910.0 | ||
| 264 | 0 | _c20150212 | |
| 008 | 201502s 0 0 eng d | ||
| 022 | _a1932-6203 | ||
| 024 | 7 |
_a10.1371/journal.pone.0090981 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWills, Edgar S | |
| 245 | 0 | 0 |
_aFecal microbial composition of ulcerative colitis and Crohn's disease patients in remission and subsequent exacerbation. _h[electronic resource] |
| 260 |
_bPloS one _c2014 |
||
| 300 |
_ae90981 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntimetabolites _xtherapeutic use |
| 650 | 0 | 4 |
_aColitis, Ulcerative _xdrug therapy |
| 650 | 0 | 4 |
_aCrohn Disease _xdrug therapy |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 |
_aFeces _xmicrobiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenetic Variation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Factors _xtherapeutic use |
| 650 | 0 | 4 |
_aIntestines _xmicrobiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMercaptopurine _xtherapeutic use |
| 650 | 0 | 4 |
_aMicrobiota _xgenetics |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aRNA, Ribosomal, 16S _xgenetics |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aJonkers, Daisy M A E | |
| 700 | 1 | _aSavelkoul, Paul H | |
| 700 | 1 | _aMasclee, Ad A | |
| 700 | 1 | _aPierik, Marieke J | |
| 700 | 1 | _aPenders, John | |
| 773 | 0 |
_tPloS one _gvol. 9 _gno. 3 _gp. e90981 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0090981 _zAvailable from publisher's website |
| 999 |
_c23621868 _d23621868 |
||